ClassID:

21537

A61K51/0431 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings

Recent Application in this class:
#1
20250360236
2025-11-27

PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS

#2
20250339565
2025-11-06

METHOD FOR SYNTHESIZING IODO- OR ASTATOARYL COMPOUNDS USING ARYLSULFONIUM SALTS

#3
20240051967
2024-02-15

BICYCLIC COMPOUNDS FOR DIAGNOSIS AND THERAPY

#4
20230159762
2023-05-25

NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION

#5
20210346526
2021-11-11

NOVEL DEUTERIUM SUBSTITUTED POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS AND THEIR PHARMACOLOGICAL APPLICATION

#6
20200360543
2020-11-19

RADIOTRACERS FOR IMAGING ER-POSITIVE BREAST CANCER

#7
20200299305
2020-09-24

Bicyclic compounds for diagnosis and therapy

#8
20200230263
2020-07-23

Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application

#9
20190367537
2019-12-05

IN VIVO STABLE HG-197(M) COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF IN NUCLEAR MEDICAL DIAGNOSTICS AND ENDORADIONUCLIDE THERAPY (THERANOSTICS)

#10
20190224346
2019-07-25

RADIOTRACERS FOR IMAGING ER-POSITIVE BREAST CANCER

#11
20190100654
2019-04-04

NIR to SWIR fluorescent compounds for imaging and detection

#12
20190071450
2019-03-07

BICYCLIC COMPOUNDS FOR DIAGNOSIS AND THERAPY

#13
20180344882
2018-12-06

Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application

#14
20170189566
2017-07-06

Alpha-synuclein ligands

#15
20170000913
2017-01-05

Nuclear medicine diagnostic imaging agent

#16
20160158388
2016-06-09

Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation

#17
20140275539
2014-09-18

STABILIZATION OF RADIOIODINATED AND ASTATINATED PHARMACEUTICALS AND IMAGING AGENTS

#18
20120251448
2012-10-04

Compounds for Use in the Detection of Neurodegenerative Diseases

#19
20110190492
2011-08-04

DIAGNOSTIC PROBE FOR CONFORMATION DISEASE

#20
20100278733
2010-11-04

COMPOSITION FOR DIAGNOSIS OF AMYLOID-RELATED DISEASE

#21
20100015053
2010-01-21

Radiolabelled TRP M8 receptor ligands

#22
20090185975
2009-07-23

DIAGNOSTIC PROBE FOR CONFORMATION DISEASE

#23
20090169475
2009-07-02

RADIOLABELED DERIVATIVES OF POTENT CHYMASE INHIBITORS

#24
20080299041
2008-12-04

HETEROCYCLIC INDENE DERIVATIVES AND THEIR RADIOISOTOPE LABELED COMPOUNDS FOR IMAGING BETA-AMYLOID DEPOSITION

#25
20080292547
2008-11-27

Novel Imaging Agents for Fibrosis

#26
20060275215
2006-12-07

Novel imaging agents

#27
20050260126
2005-11-24

Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein